Regulatory Effects of Fenofibrate and Atorvastatin on Lipoprotein A-I and Lipoprotein A-I:A-II Kinetics in the Metabolic Syndrome

OBJECTIVE: Subjects with the metabolic syndrome have reduced HDL cholesterol concentration and altered metabolism of high-density lipoprotein (Lp)A-I and LpA-I:A-II particles. In the metabolic syndrome, fenofibrate and atorvastatin may have differential effects on HDL particle kinetics. RESEARCH DES...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Dick C., Watts, Gerald F., Ooi, Esther M.M., Rye, Kerry-Anne, Ji, Juying, Johnson, Anthony G., Barrett, P. Hugh R.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768190/
https://www.ncbi.nlm.nih.gov/pubmed/19651918
http://dx.doi.org/10.2337/dc09-0519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768190/
https://www.ncbi.nlm.nih.gov/pubmed/19651918
http://dx.doi.org/10.2337/dc09-0519

Ejemplares similares